CDKN1C anticorps (AA 266-316)
Aperçu rapide pour CDKN1C anticorps (AA 266-316) (ABIN1977657)
Antigène
Voir toutes CDKN1C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 266-316
-
Specificité
- Region between residue 266 and 316 of human cyclindependent kinase inhibitor p57 using the numbering given in entry NP_000067.1 (GeneID 1028).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: IP (2 - 5 μg/mg lysate)
Not recommended for: WB -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Autre désignation
- CDKN1C / p57 Kip2
-
Sujet
-
Name/Gene ID: CDKN1C
Synonyms: CDKN1C, BWS, KIP2, IMAGE, p57Kip2, p57, p57 KIP2, Beckwith-Wiedemann syndrome, WBS, BWCR -
ID gène
- 1028
-
Pathways
- Cycle Cellulaire, Dopaminergic Neurogenesis
Antigène
-